go back

Ciltacabtagene Autoleucel (Carvykti) CAR-T Therapy

Delaware rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Professionalmedian $1,995,262 · 10th to 90th $1,995,262 to $1,995,262
$2Mprofessional $1,995,262

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,995,262.31
Median
$1,995,262.31
Typical High
$1,995,262.31